Dr. Joe Tafur, MD Episode Summary: For the last two years, Modern Spirit, a nonprofit dedicated to demonstrating the value of spiritual healing in modern healthcare, has been collaborating with MAPS and the USC Department of Psychiatry. Participating study centers have been collecting saliva samples before and after the MDMA-assisted Psychotherapy intervention for PTSD. The … Read moreEpigenetics in Psychedelic-Assisted Therapies: Spiritual Healing in Modern Healthcare [ONLINE]
The Synthesis Institute is hosting Guiding the Unbound Mind: What Every Practitioner Must Know About Working with Psychedelics, an online psychedelic expert forum featuring former Imperial College London Lead Psychedelic Researcher and Clinical Director of The Synthesis Institute, Dr. Rosalind Watts, co-founder of Guild of Guides Netherlands and Lead Facilitator at The Synthesis Institute, Daan Keiman, … Read moreGuiding the Unbound Mind: What Every Practitioner Must Know About Working With Psychedelics [ONLINE]
Virtual CE/CME Continuing Education Class Join psychedelic therapy luminary Bill Richards, Ph.D. and rising researcher Brian D. Richards, Psy.D. for an all-day exploration of the history and potential of psilocybin-assisted psychotherapy.
Virtual CE/CME Continuing Education Class Join MDMA research pioneers Michael Mithoefer, MD and Annie Mithoefer, BSN for an in-depth exploration of the history, present, and future of MDMA-assisted psychotherapy for clinical applications such as treatment of PTSD and depression.
Presenter: Andrew Penn, RN, MS, PMHMP Discussant: Patricia Penn, LCSW, PhD Description: The use of psychedelic medicines such as MDMA and psilocybin as catalysts to psychotherapy has been receiving a lot of press as they advance through clinical trials, which if successful, would lead to FDA approval for the use of these medicines as adjuncts … Read moreGetting Unstuck: the promise of psychedelic assisted therapies [ONLINE]
Measure 109: What It Does. Who It Helps. Pioneering research at America’s top universities shows that psilocybin therapy can help those suffering from depression, anxiety, and addiction. Measure 109 is a carefully crafted ballot initiative supported by medical experts, veterans, and people from over 300 Oregon cities to bring this “breakthrough therapy” to Oregon. More … Read moreA Discussion with Oregon’s Measure 109 Campaign Team [ONLINE]
Join Greens MP Cate Faehrmann for a discussion on the emerging field of psychedelic-assisted therapy. About this Event The emerging field of psychedelic-assisted therapy is showing breakthrough results for treatment-resistant mental disorders. Psilocybin mushrooms, LSD, MDMA and Ketamine are just some of the drugs being used to successfully treat anxiety, depression, PTSD and addiction. At … Read morePsychedelics as Medicine [ONLINE]
Join Sam Chapman, campaign manager for the Oregon IP 34 Initiative, seeking to create the first ever state-wide regulated psilocybin program in the country. Sam will provide an update on the campaign’s progress, discuss his experience as campaign manager, and offer insights as to what the future of psilocybin therapy will look like in Oregon and beyond, … Read moreThe Future of Psilocybin Therapy: The Oregon Approach [ONLINE]